Mabion S.A. (WSE:MAB)
9.57
-0.06 (-0.62%)
Jul 25, 2025, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 154.67 million as of July 25, 2025. Its market cap has decreased by -44.81% in one year.
Market Cap
154.67M
Enterprise Value
134.55M
Revenue
37.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.57
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 154.67M, an increase of 66.29%. That is a compound annual growth rate of 3.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2025 | 154.67M | 7.53% |
Dec 30, 2024 | 143.84M | -50.96% |
Dec 29, 2023 | 293.35M | -13.57% |
Dec 30, 2022 | 339.41M | -65.63% |
Dec 30, 2021 | 987.46M | 246.59% |
Dec 30, 2020 | 284.90M | -73.03% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NEUCA | 3.00B |
Voxel | 1.80B |
Synektik Spólka Akcyjna | 1.79B |
Celon Pharma | 1.30B |
Ryvu Therapeutics | 723.66M |
Selvita | 660.80M |
Centrum Medyczne ENEL-MED | 565.61M |
Bioceltix | 531.84M |